207 related articles for article (PubMed ID: 36998469)
1. Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer.
Yang G; Chen X; Quan Z; Liu M; Guo Y; Tang Y; Peng L; Wang L; Wu Y; Wu X; Liu J; Zheng Y
Front Oncol; 2023; 13():1048521. PubMed ID: 36998469
[TBL] [Abstract][Full Text] [Related]
2. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
[TBL] [Abstract][Full Text] [Related]
3. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
5. Construction and analysis of lncRNA-associated ceRNA network identified potential prognostic biomarker in gastric cancer.
Peng J; Zhu Y; Dong X; Mao X; Lou Y; Mu Y; Xue D; Zhou H
Transl Cancer Res; 2019 Aug; 8(4):1116-1128. PubMed ID: 35116854
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y
Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563
[TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
Wang J; Zhang C; Wu Y; He W; Gou X
Cancer Cell Int; 2019; 19():327. PubMed ID: 31827401
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma.
Cai Y; Cui J; Wang Z; Wu H
Transl Cancer Res; 2022 Jul; 11(7):1994-2012. PubMed ID: 35966302
[TBL] [Abstract][Full Text] [Related]
9. Integrated Bioinformatics and Experimental Analysis of Long Noncoding RNA Associated-ceRNA as Prognostic Biomarkers in Advanced Stomach Adenocarcinoma.
Chen Y; Gao X; Dai X; Xia Y; Zhang X; Sun L; Zhu Y
J Cancer; 2024; 15(6):1536-1550. PubMed ID: 38370380
[TBL] [Abstract][Full Text] [Related]
10. Roles of lncRNA MAGI2-AS3 in human cancers.
Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
Hu R; Wu P; Liu J
Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-miRNA-mRNA Networks of Gastrointestinal Cancers Representing Common and Specific LncRNAs and mRNAs.
Dastsooz H; Alizadeh A; Habibzadeh P; Nariman A; Hosseini A; Mansoori Y; Haghi-Aminjan H
Front Genet; 2021; 12():791919. PubMed ID: 35140741
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S
Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of the TRHDE-AS1/hsa-miR-449a/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer.
Lian X; Pang L; Zhou H; Liu S
Biofactors; 2024 May; ():. PubMed ID: 38818922
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
Cao C; Zhou S; Hu J
Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma.
Shi Y; Zhang DD; Liu JB; Yang XL; Xin R; Jia CY; Wang HM; Lu GX; Wang PY; Liu Y; Li ZJ; Deng J; Lin QL; Ma L; Feng SS; Chen XQ; Zheng XM; Zhou YF; Hu YJ; Yin HQ; Tian LL; Gu LP; Lv ZW; Yu F; Li W; Ma YS; Da F
Mol Ther Nucleic Acids; 2021 Mar; 23():702-718. PubMed ID: 33575116
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
Gong J; Ma L; Peng C; Liu J
Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
20. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
